MedTrace Logo

Tailored Information About the Coronavirus for Patients With Chronic Kidney Disease

NCT04854382 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 215

Last updated 2022-03-29

No results posted yet for this study

Summary

Randomized clinical trial focusing on the effect of tailored information on Covid-19 for patients with chronic kidney disease stage 5 on health literacy, anxiety and self-perceived health.

Conditions

  • Renal Insufficiency, Chronic

Interventions

BEHAVIORAL

Tailored information

Tailored information about coronavirus for patients with chronic kidney disease by information videos followed by a teach back procedure

Sponsors & Collaborators

  • Ivar Anders Eide

    lead OTHER

Principal Investigators

  • Ivar A Eide, PhD · University Hospital, Akershus

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-14
Primary Completion
2022-03-10
Completion
2023-12-31

Countries

  • Norway

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04854382 on ClinicalTrials.gov